Featured
Edwards Sees Boost in Heart Valve Sales
NF Research Jul 25, 2026
Patient Briefs Jul 24, 2026
Tumor Watch Jul 24, 2026
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they...
Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible...
Read our latest NF Research articles.
Edwards sees boost in heart valve sales driven by increasing demand for TAVR devices and...
Explore the 2026 pulmonary embolism guidelines released by the American Heart Association and ACC, detailing...
Learn practical drink spiking prevention tips from pharmacists, including how OTC test strips work and...
Edwards sees boost in heart valve sales driven by increasing demand for TAVR devices and newer treatments.
Edwards sees boost in heart valve sales driven by increasing demand for TAVR devices and newer treatments.
Dexcom joins the FDA’s digital health pilot program to accelerate innovative medical technologies with real-world data and faster approvals.
US adult obesity rates climbed to 41% between 1999 and 2023. New data reveals severe obesity doubling and abdominal obesity...
Explore the latest breast cancer treatment developments and the challenges of sequencing antibody-drug conjugates to optimize patient outcomes in oncology.
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when CAR T‑cell treatment isn’t possible,...
Bispecific therapy program by American Oncology Network offers safe outpatient dosing guidelines for community clinics, ensuring close monitoring and patient...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they are improving outcomes for patients...
Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage 3 NSCLC, according to a...
GLP-1 receptor agonists can interact with oral chemotherapy, jeopardizing treatment effectiveness for diabetes and weight loss patients using glp-1 agents.
President Trump directs CMS to allocate $10 billion for rural health transformation under the One Big Beautiful Bill Act of...